The law of diminishing returns in clinical medicine: How much risk reduction is enough?

Journal of the American Board of Family Medicine

Volumn 23, Issue 3, 2010, Pages 371-375

  Mold, James W ^a   Hamm, Robert M ^a   McCarthy, Laine H ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical decision making; Evidence based medicine; Risk reduction

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INFLUENZA VACCINE; LOOP DIURETIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PNEUMOCOCCUS VACCINE; RIBOFLAVIN; SPIRONOLACTONE; TANACETUM PARTHENIUM EXTRACT; VITAMIN D;

AEROBIC EXERCISE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL DECISION MAKING; CLINICAL FEATURE; DRUG MEGADOSE; HEALTH CARE COST; HEART INFARCTION; HEART REHABILITATION; HEMOGLOBIN BLOOD LEVEL; HIP FRACTURE; HUMAN; HYPERTENSION; INFLUENZA VACCINATION; LOW DRUG DOSE; MALE; MIGRAINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PNEUMONIA; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STROKE; SYSTOLIC HEART FAILURE; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MYOCARDIAL INFARCTION; PATIENT CARE PLANNING; PHYSICIAN'S PRACTICE PATTERNS; RISK; RISK REDUCTION BEHAVIOR; STROKE;

EID: 77952133532     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2010.03.090178     Document Type: Article

References (30)

1. Economy Professor. Law of diminishing returns. The Professor Network, 2009. Available at www. economyprofessor.com/economictheories/law-of- diminishing-returns.php. Accessed 14 April 2009.
2. Johnson HA. Diminishing returns on the road to diagnostic certainty. JAMA 1991;265:2229-2231
3. Sonnenberg A. Diminishing returns on sequential interventions of gastroenterology. Eur J Gastroenterol Hepatol 2008;20:465-468 (Pubitemid 351533884)
4. Luke B, Hediger ML, Scholl TO. Point of diminishing returns: when does gestational weight gain cease benefiting birthweight and begin adding to maternal obesity? J Matern Fetal Med 1996;5:166-173
5. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008; 31(Suppl 1):S12-S54.
6. American Diabetes Association. Living with diabetes. Diabetes PHD. Available at http://www.diabetes. org/living-with-diabetes/complications/ diabetes-phd/. Accessed 15 March 2010.
7. Eddy DM, Schlessinger L. Validation of the Archimedes diabetes model. Diabetes Care 2003;26: 3102-3110
8. Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care 2003;26: 3093-3101
9. Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomized placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008;337:a1840.
10. Ogawa H, Nakayama M, Morimoto T, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes. JAMA 2008;300:2134-2141
11. US Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events. Report no. APPIP02-0004. Washington, DC: Agency for Healthcare Research and Quality.
12. Kannel WB, Schatzkin A. Risk factor analysis. Prog Cardiovasc Dis 1983;26:309-332
13. Gerstein HC, Pogue J, Mann JFE, et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 2005;48:1749-1755 (Pubitemid 41317828)
14. Haffner SM. Is there a glycemic threshold?. Arch Intern Med 1997;157:1791.
15. Krolewski AS, Laffel LMB, Krolewski BA, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminaria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1251-1255
16. Orchard TJ, Forrest KY-Z, Ellis D, Becker D. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus: the glycemic threshold revisited. Arch Intern Med 1997;157:1851-1856 (Pubitemid 27381117)
17. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997;127:788-795 (Pubitemid 27465546)
18. Warram JH, Manson JE, Krolewski AS. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1305-1306
19. Action to Control Cardiovascular Risk in Diabetes Study Group (ACCORD), Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
20. Courtney DL. Medication reduction strategies. Compr Ther 1996;22:318-323
21. Stoehr GR, Lu S-Y, Lavery L, Vander Bilt J, Saxton JA, Chang C-C. Factors associated with adherence to medication regimens in older primary care patients: the Steel Valley Seniors Survey. Am J Geriatr Pharmacother 2008;6:255-263
22. Williams AF, Manias E, Walker R. Adherence to multiple, prescribed medications in diabetic kidney disease: a qualitative study of consumers' and health professionals' perspectives. Int J Nurs Stud 2008;45:1742-1756
23. Boyd CM, Darer J, Boult C, Fried LP, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple-co-morbid diseases: implications for pay for performance. JAMA 2005;294:716-724 (Pubitemid 41159291)
24. Mold JW. An alternative conceptualization of health and health care: its implications for geriatrics and gerontology. Educ Gerontol 1995;21:85-101.
25. Mold JW, Blake GH, Becker LA. Goal-oriented medical care. Fam Med 1991;23:46-51.
26. Mold JW, Hamm R, Scheid D. Evidence-based medicine meets goal-directed health care. Fam Med 2003;35:360-364 (Pubitemid 36566124)
27. Lee TH. "Me-Too" products-friend or foe? N Engl J Med 2004;350:211-212
28. Zubialde JP, Mold JW. Relational value: bridging the worldview gap between patients and health systems. Fam Med 2001;33:393-398
29. Jacobson TA. "The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline? Ann Intern Med 2000;133:549-554
30. Learmonth ID. Total hip replacement and the law of diminishing returns. J Bone Joint Surg 2006;88-A: 1664-1673